PubRank

Claudius Conrad

Author PubWeight™ 46.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 2009 7.39
2 Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 2010 5.59
3 Hepatic portal venous gas: the ABCs of management. Arch Surg 2009 3.76
4 STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. Cancer Res 2011 2.35
5 Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma. Ann Surg 2009 1.08
6 Esoteric or exoteric? Music in medicine. Medscape J Med 2008 1.07
7 Surgical and endovascular treatment of symptomatic aberrant right subclavian artery (arteria lusoria). Vascular 2007 1.06
8 Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma. Ann Surg 2011 1.03
9 Parenchymal-sparing Hepatectomy in Colorectal Liver Metastasis Improves Salvageability and Survival. Ann Surg 2016 0.98
10 Mesenchymal stem cell-based tumor-targeted gene therapy in gastrointestinal cancer. Stem Cells Dev 2012 0.97
11 Laparoscopic Transabdominal With Transdiaphragmatic Access Improves Resection of Difficult Posterosuperior Liver Lesions. Ann Surg 2015 0.93
12 Concise review: genetically engineered stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancy. Stem Cells 2013 0.93
13 Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy. J Surg Oncol 2014 0.92
14 Posterior approach for laparoscopic pancreaticoduodenectomy to prevent replaced hepatic artery injury. Ann Surg Oncol 2013 0.89
15 Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model. Cancer Immunol Immunother 2014 0.87
16 Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study. Cancer Immunol Immunother 2011 0.87
17 Ninety-day Postoperative Mortality Is a Legitimate Measure of Hepatopancreatobiliary Surgical Quality. Ann Surg 2015 0.86
18 Laparoscopic portal vein ligation with in situ liver split for failed portal vein embolization. Ann Surg 2012 0.85
19 Music for healing: from magic to medicine. Lancet 2010 0.85
20 Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study. Ann Surg 2015 0.84
21 Molecular study of time dependent changes in DNA stability in soil buried skeletal residues. Forensic Sci Int 2007 0.84
22 Is complete liver resection without resection of synchronous lung metastases justified? Ann Surg Oncol 2014 0.84
23 Surgery for metastasis to the pancreas: is it safe and effective? J Surg Oncol 2013 0.84
24 Combined resection of colorectal hepatic-pulmonary metastases shows improved outcome over chemotherapy alone. Langenbecks Arch Surg 2013 0.83
25 Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer. Ann Surg Oncol 2014 0.83
26 How surgical residents use social media. Surgery 2011 0.82
27 The impact of music on hypermetabolism in critical illness. Curr Opin Clin Nutr Metab Care 2008 0.81
28 Using a 'no drain' policy in 342 laparoscopic hepatectomies: which factors predict failure? HPB (Oxford) 2013 0.80
29 The impact of music on metabolism. Nutrition 2012 0.80
30 Technique for chest compressions in adult CPR. World J Emerg Surg 2011 0.80
31 After Pancreatectomy, the “90 Days from Surgery” Definition Is Superior to the “30 Days from Discharge” Definition for Capture of Clinically Relevant Readmissions. J Gastrointest Surg 2016 0.79
32 Three-dimensional volumetry in 107 normal livers reveals clinically relevant inter-segment variation in size. HPB (Oxford) 2013 0.78
33 Cell surface engineering using glycosylphosphatidylinositol anchored tissue inhibitor of matrix metalloproteinase-1 stimulates cutaneous wound healing. Wound Repair Regen 2014 0.76
34 Low degree of formal education and musical experience predict degree of music-induced stress reduction in relatives and friends of patients: a single-center, randomized controlled trial. Ann Surg 2013 0.76
35 Survival After Resection of Gastrointestinal Stromal Tumor and Sarcoma Liver Metastases in 146 Patients. J Gastrointest Surg 2015 0.75
36 Volume regeneration of segments 2 and 3 after right portal vein embolization in patients undergoing two-stage hepatectomy. J Gastrointest Surg 2014 0.75
37 Mesenchymal stem cells in regenerative medicine: of hopes and challenges. Medscape J Med 2009 0.75
38 IRCAD recommendation on safe laparoscopic cholecystectomy. J Hepatobiliary Pancreat Sci 2017 0.75
39 Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States. Oncology 2017 0.75
40 Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases. Ann Surg 2017 0.75
41 RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases. Ann Surg 2017 0.75
42 Radiofrequency Ablation of Hepatic Tumor: Subjective Assessment of the Perilesional Vascular Network on Contrast-Enhanced Computed Tomography Before and After Ablation Can Reliably Predict the Risk of Local Recurrence. J Comput Assist Tomogr 2017 0.75
43 Open Pancreaticoduodenectomy Case Volume Predicts Outcome of Laparoscopic Approach: A Population-based Analysis. Ann Surg 2016 0.75
44 Comprehensive Complication Index Predicts Cancer-specific Survival After Resection of Colorectal Metastases Independent of RAS Mutational Status. Ann Surg 2016 0.75
45 APC and PIK3CA Mutational Cooperativity Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colorectal Liver Metastases. Ann Surg 2017 0.75
46 Image of the month. Cholecystocutaneous fistula (Jean-Louis Petit phlegmon). Arch Surg 2011 0.75